Live Breaking News & Updates on De Schedule Dual Orexin Receptor Antagonist Class

The petition with the US DEA is aiming to remove dual orexin receptor antagonist medications from the Controlled Substances Act due to negligible potential for abuse. ....

United States , Vaughn Mccall , Jean Paul Clozel , Health Behavior At Augusta University , Drug Administration , Idorsia Pharmaceuticals , Department Of Psychiatry , Drug Enforcement Administration , Citizen Petition , Paul Clozel , Chief Executive Officer , Controlled Substances , Controlled Substances Act , Case Distinguished Chair , Health Behavior , Augusta University , Files Petition , Purging Them , De Schedule Dual Orexin Receptor Antagonist Class ,